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LETTERS TO THE EDITOR 
Leiomyosarcoma of the pulmonary veins extending 
into the left atrium or left atrial leiomyosarcoma: 
Multimodality therapy 
To the Editor: 
We read with interest the article by Shimono and associates 
(J Thorac Cardiovasc Surg 1998;115:469-1) titled "Pulmonary 
Leiomyosarcoma Extending Into Left Atrium or Pulmonary 
Trunk: Complete Resection With Cardiopulmonary Bypass." 
Although it is true that primary pulmonary leiomyosarcoma is 
a rare tumor, we think that the second case reported consisted 
in a left atrial leiomyosarcoma originating in the atrial wall and 
extending into the pulmonary veins. The most important series 
in the world concerning this tumor is the experience of the 
Armed Forces Institute of Pathology (AFlP),1 with 12 cases 
reported and 6 cases surgically resected. Controversy still 
exists conceming their origin. The AFlP clearly demonstrated 
that the majority of cardiac leiomyosarcomas arise in the left 
atrium; at surgery, some of these appear to arise from a pul-
monary vein. For these reasons, the cell origin of cardiac 
leiomyosarcoma may reside in the smooth muscle media of 
pulmonary veins. However, it is likely that some leiomyosar-
comas originate within the left atrium itself, because the left 
atrium is a preferred site of origin of most cardiac sarcomas, 
and because the subendocardial lining of the atrium normally 
contains bundles of smooth muscle cells. Their large size at the 
time of diagnosis makes assessment of the precise site of ori-
gin impossible in most cases. To the best of our knowledge, 20 
cases of left atrial leiomyosarcomas have been previously 
reported in the literature (Table I). The mean postoperative sur-
vival in those patients is 6.8 months. I•2 In our opinion, 7 
months is insufficient follow-up time to evaluate whether 
surgery without adjuvant therapy has been successful. 
Shimono and associates stated that their case was the first 
Table I. Primary leiomyosarcoma o[ the left atrial cavity 
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report of the resection of a left atrial tumor by thoracotomy 
through the rib bed, and we understand why the majority of 
cardiac surgeons relating their experience preferred the ster-
notomy approach. Surgery is indicated to obtain a definitive 
histologic diagnosis and to evaluate the prognosis, and as 
much of the tumor as possible must be removed during the 
operation. Visualization of tumors in the left atrium appears to 
be more difficult, and detection of unresected portions of 
tumor after the operation can be extremely difficult if not 
impossible.3 This, evidently, can be extremely difficult in 
tumors of the left atrium with involvement of the pulmonary 
veins4 by the thoracotomy approach. 
KrUger and associates5 have analyzed 19 cases of leio-
myosarcoma of the pulmonary artery. After surgery, the median 
survival time of the patients was prolonged to 10 months. The 
surgical technique (pneumonectomy compared with mere 
"excision" of the tumor from the vascular bed) did not have any 
effect on the survival time (P = .43). Resection involving pneu-
monectomy may lead to recurrence of the tumor in the remain-
ing lung owing to the proximal location of the tumor. We have 
treated I patient with leiomyosarcoma of the pulmonary artery 
trunk. The tumor was successfully resected without pneu-
monectomy with a convenient follow-up of I year. 
Regarding adjuvant chemotherapy, which was not indicated 
in the 2 cases reported by Shimono and associates, recent 
reports seemed to demonstrate the benefit of a chemotherapy 
regimen in those type of tumors.4.6 Doxorubicin-based post-
operative adjuvant therapy has been used on the basis of its 
effectiveness in treating soft tissue sarcomas in other loca-
tions.6 Because of the poor prognosis of patients with leio-
myosarcomas of the heart and the great vessels, the recom-
mended therapy is surgery followed by chemotherapy and 
radiation.2.4 Some authors4•5 have demonstrated that radio-
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therapy and/or chemotherapy administered in the postopera-
tive period was followed by a significantly prolonged survival 
time (P = .023). Pulmonary metastases are present in up to 
60%4 of patients. Distal microembolization is common; 
therefore adjuvant therapy, even in the absence of pulmonary 
nodules, would seem appropriate. In conclusion, total surgi-
cal resection (which was best performed with the aid of car-
diopulmonary bypass through a median sternotomy), with the 
addition of chemotherapy, radiotherapy, or both, should offer 
these patients significant palliation and an opportunity for 
increased length of survival. 
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Reply to the Editor: 
We thank Babatasi, Massetti, Galateau, and Khayat for their 
interest in our article. We shall first respond to their comment 
that the tumor in the second case originated in the atrial wall 
and extended into the pulmonary vein. Because of space limi-
tations in our article, we did not show the photographs of the 
operative specimen and histologic findings in detail. On the 
macroscopic findings, the tumor filled the left lower pulmonary 
vein and was strongly attached to the wall of the pulmonary 
vein. Most of the intra-atrial tumor was free from the atrial wall 
and weakly attached to the atrial wall around the orifice of the 
pulmonary vein (Fig 1). Therefore, the tumor, the left lung, and 
the left side of the left atrial wall were excised en bloc. 
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Fig 1. A, Left pneumonectomy specimen with the tumor 
mass and the left atrial wall. B, Macroscopic finding of the 
left lower pulmonary vein and the tumor. The tumor is strongly 
attached to the wall of the pulmonary vein (arrow). 
Fig 2. Histologic findings at the portion of the tumor strongly 
attached to the vein wall. 
Histologic examination revealed that the tumor arose from the 
media of the pulmonary vein at the point where it was strongly 
attached (Fig 2). 
